Industry News

Industry News

Advanced Lymphoma Patients Receiving Radioimmunotherapy Likely To Live Longer

Jun 13, 2013

A new patient protocol for aggressive and recurrent lymphoma that combines intensive chemotherapy and radioimmunotherapy (RIT) may become the most powerful cancer-killing therapy available, with the hope that patients' lymphoma can be eradicated as they prepare for bone marrow transplant, said researchers at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging... Read More

Non-Hodgkin Lymphoma Survival Predicted By Dose Analysis

Jun 13, 2013

Outcomes can be bleak for non-Hodgkin lymphoma (NHL), a cancer that develops in the white blood cells of the immune system... Read More

Malignant Cells Not Directly Targeted By Hormonal Treatment For Endometrial Cancer

Jun 13, 2013

Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, according to a study from the G.O. Discovery Lab team and collaborators at UCLA. Like tumors of the breast and prostate, endometrial cancer is regulated by hormones... Read More

Pediatric PET Imaging Of Gliomas Gets A Boost With An Easier-To-Manufacture Imaging Agent

Jun 13, 2013

A relatively new weapon in the fight against childhood brain cancer has emerged that improves upon standard magnetic resonance imaging (MRI) by providing information about tumor metabolism and extent of cancer in children diagnosed with glioma, a growth caused by the abnormal division of glial cells in the brain, say researchers at the Society of Nuclear Medicine and Molecular ... Read More

PET And MR Predict Chemotherapy's Ability To Prolong Life Of Breast Cancer Patients

Jun 13, 2013

For patients with advanced breast cancer, positron emission tomography (PET) and magnetic resonance (MR) imaging can improve quality of life and survival by providing physicians with information on the effectiveness of chemotherapy prior to surgery, said researchers presenting at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging... Read More

Allergic And Autoimmune Diseases Connected, Implications For The Development Of New Therapies To Target Cancer

Jun 12, 2013

A group of scientists has discovered that a gene called Bach2 may play a central role in the development of a range of allergic and autoimmune diseases, such as multiple sclerosis, asthma, Crohn's disease, celiac disease, and type-1 diabetes. The research has implications for the development of new therapies to target cancer... Read More

New Study Recommends Autologous Blood Donations Prior To Knee And Hip Replacement For Selected Patients Only

Jun 12, 2013

"Patients not suffering from anaemia before an operation do not need autologous blood donations prior to a primary knee or hip implantation. This routine measure has not been medically indicated for a long time in all cases and often only leads to an increased transfusion rate. At the same time, many autologous blood donations are disposed of after the operation because they are not needed... Read More

Chronic Myeloid Leukemia Patients On Kinase Inhibitors Report Serious Quality-Of-Life Issues

Jun 12, 2013

Researchers at Moffitt Cancer Center have determined that chronic myeloid leukemia patients who are treated with a class of oral chemotherapy drugs known as a tyrosine kinase inhibitors have significant side effects and quality-of-life issues that need to be addressed. Some of these issues include depression, fatigue, nausea and change of appearance... Read More

Cytosine Methylation Likely Plays A Key Role In Fueling Pediatric Acute Lymphoblastic Leukemia

Jun 12, 2013

Changes in an epigenetic mechanism that turns expression of genes on and off may be as important as genetic alterations in causing pediatric acute lymphoblastic leukemia (ALL), according to a study led by scientists at St. Jude Children's Research Hospital and published online in the Journal of Clinical Investigation... Read More

Benzophenones Derived From African Medicinal Plants May Be Effective Against Multi-Drug Resistant Cancers

Jun 12, 2013

African medicinal plants contain chemicals that may be able to stop the spread of cancer cells. This is the conclusion of researchers following laboratory experiments conducted at Johannes Gutenberg University Mainz (JGU). The plant materials will now undergo further analysis in order to evaluate their therapeutic potential... Read More

Previous Page   Next Page